Center-Authored Papers
Filters: Author is Self, Steven G [Clear All Filters]
.
2008.
Identifying trait clusters by linkage profiles: application in genetical genomics.. Bioinformatics (Oxford, England). 24(7):958-64. Abstract
.
2008.
.
2008.
The use of nonhuman primate models in HIV vaccine development.. PLoS medicine. 5(8):e173.
.
2008.
.
2008.
Inclusion of adolescents in preventive HIV vaccine trials: public health policy and research design at a crossroads.. Journal of acquired immune deficiency syndromes (1999). 47(1):86-92. Abstract
.
2008.
Measuring the public-health impact of candidate HIV vaccines as part of the licensing process.. The Lancet infectious diseases. 8(3):200-7. Abstract
.
2008.
Towards prediction of degenerate CTL epitope recognition.. Human vaccines. 4(2):115-21. Abstract
.
2008.
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis.. Lancet. 372(9653):1894-905. Abstract
.
2008.
Evaluating a surrogate endpoint at three levels, with application to vaccine development.. Statistics in medicine. 27(23):4758-78. Abstract
.
2008.
Development of an automated analysis system for data from flow cytometric intracellular cytokine staining assays from clinical vaccine trials.. Cytometry. Part A : the journal of the International Society for Analytical Cytology. 73(9):847-56. Abstract
.
2008.
.
2009.
Power to detect the effects of HIV vaccination in repeated low-dose challenge experiments.. The Journal of infectious diseases. 200(4):609-13. Abstract
.
2009.
Neonatal innate TLR-mediated responses are distinct from those of adults.. Journal of immunology (Baltimore, Md. : 1950). 183(11):7150-60. Abstract
.
2009.
Simultaneous Evaluation of the Magnitude and Breadth of a Left and Right Censored Multivariate Response, with Application to HIV Vaccine Development.. Statistics in biopharmaceutical research. 1(1):81-91. Abstract
.
2009.
Response to Andrew Dunning's comment on 'evaluating a surrogate endpoint at three levels, with application to vaccine development'.. Statistics in medicine. 28(4):716-9.
.
2009.
Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection.. Journal of virology. 83(2):757-69. Abstract
.
2009.
.
2009.
.
2010.
Equivalence of ELISpot assays demonstrated between major HIV network laboratories.. PloS one. 5(12):e14330. Abstract
.
2010.
Ontogeny of Toll-like receptor mediated cytokine responses of human blood mononuclear cells.. PloS one. 5(11):e15041. Abstract
.
2010.
Magnitude and breadth of a nonprotective neutralizing antibody response in an efficacy trial of a candidate HIV-1 gp120 vaccine.. The Journal of infectious diseases. 202(4):595-605. Abstract
.
2010.
Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies.. Journal of virology. 84(3):1439-52. Abstract
.
2010.
Estimation of the initial viral growth rate and basic reproductive number during acute HIV-1 infection.. Journal of virology. 84(12):6096-102. Abstract
.
2010.
Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults.. AIDS research and human retroviruses. 27(5):557-567. Abstract
.
2011. Doing Business with Arnold Library
Weintraub Building, B1-010
(206) 667-4314
library@fredhutch.org
More About Arnold Library
Quick Links
- ILLiad/ILL Form
- Journals List
- Ovid - Medline
- Web of Science
- Pubmed
- Libguides
- Library Catalog
- Researcher Profiles
- Library Affiliations & Memberships
- Fred Hutch Papers (Intranet)